The stock price is likely to benefit from the potential strong performance of Neratinib in the market. The company is testing Neratinib for other indications as well, creating long term catalysts. Puma Biotechnology Inc. (NASDAQ:PBYI) stock
Stifel Nicolaus restated their buy rating on shares of Puma Biotechnology Inc …
In other news, the company just announced it'll offer new Pumpkin Spice Latte …
Puma Biotechnology Inc (NASDAQ:PBYI). Franklin Resources Inc bought 279,175 shares during the last quarter increasing its stake in Puma Biotechnology Inc (PBYI) by 94.8%. Its stake was worth $50,134,000 an increase of …
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Puma Biotechnology Inc (Symbol: PBYI) entered into oversold territory, hitting an RSI reading of 24.1, after changing hands as …
This suggests that analysts have very recently bumped up their estimates for PBYI, giving the stock a Zacks Earnings ESP of +3.33% heading into earnings season. A positive reading for the Zacks Earnings ESP has proven to be very …